Skip to content
Brand AI

Adakveo

Request correction

Product brand

UnclaimedRead 4× by AI crawlers

Adakveo is a pharmaceutical brand.

Last updated September 15, 2026

AI crawler reads

4requests

1companies
  • Anthropic4
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Adakveo is a pharmaceutical brand. The available evidence confirms only its identity as a pharmaceutical brand; no further brand history, ownership, or product details are supported by the supplied snippets.

Recent events

  • Reported

    FDA approves Adakveo for sickle cell disease pain crises[1]

    The FDA approved crizanlizumab (Adakveo, Novartis) to reduce the frequency of pain crises among people with sickle cell disease; the article states it is indicated for patients aged 16 or older.

Read more

Sources2 sources

  1. 1FDA批准Adakveo用于镰状细胞病疼痛危象healio.com
  2. 2FDA approves Novartis drug to treat pain crises in sickle cell disease - MedCity Newsmedcitynews.com

Cite this profile: Cite the canonical profile. /brand-wiki/adakveo · Editorial policy · How profiles are compiled